Abstract
Pursuant to Article L. 5122-6 of the Public Health Code, the High Council for Public Health has determined the minimum information required to advertise the quadrivalent vaccine diphtheria-tetanus-pertussis-polio Repevax®. Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_mmo_Repevax.pdf
Europe
France
health policy
poliomyelitis
Diphtheria
Tetanus
Poliomyelitis
Pertussis
